Academic Committee
At its meeting No. 208/22.9.2022, the University of Patras Senate approved unanimously the composition of the MSc “Cell and Gene Therapies” Curriculum Committee for the academic year 2022-23 and 2023-24 as follows:
| Name | Institution |
|---|---|
| Prof. Spyridonidis Alexandros (Director of the MSc) | Univ. of Patras |
| Prof. Mouzaki Athanasia | Univ. of Patras |
| Assistant Prof. Nika Konstantina | Univ. of Patras |
| Prof. Papageorgiou Efstathia | UniWΑ |
| Prof. Chaniotis Dimitrios | UniWΑ |
| Associate Prof. Kriebardis A. | UniWΑ |
Academic Staff / Lecturers
1st Cycle (Academic years 2021-2022 and 2022-2023)
| Name | Institution | Area of Expertise |
|---|---|---|
| Prof. Spyridonidis Alexandros | Univ. of Patras | ATMPs, GMP, Regulations, clinical |
| Prof. Mouzaki Athanasia | Univ. of Patras | Immunology |
| Prof. Taraviras Stavros | Univ. of Patras | Stem Cells |
| Prof. Lygerou Zoi | Univ. of Patras | Cell cycle |
| Prof. Gerhard Bauer | UC Davis, California, USA | GMP operations, Clinical Production |
| Prof. Mougiakakos Dimitris | University of Magdeburg, Germany | Haematology, Immunotherapy |
| Prof. Papageorgiou Efstathia | Univ. of WA | Statistical process and medical data analysis |
| Prof. Chaniotis Dimitrios | Univ. of WA | Personalized medicine |
| As. Prof. Kriebardis A. | Univ. of WA | Cell biology |
| As. Prof. Zoumboulakis P. | Univ. of WA | Biomarkers, Scientific Management |
| As. Prof. Nika Konstatnina | Univ. of Patras | Immunology, Cell signaling, T cell biology |
| Dr. Georgatzakou Chara | Univ. of WA | Cell biology |
| As. Prof. Psatha Nikoleta | Aristotle University of Thessaloniki | Ex vino & in vivo Gene Therapy |
| As. Prof. Themeli M. | Univ. of Amsterdam, Netherlands | iPS, CART cells |
| Dr. Georgios Katsouleas | Univ. of WA | Statistical process and data analysis |
| As. Prof. Hatzimichael Eleftheria | Univ. of Ioannina | |
| Dr. Vivian Tseveleki | Theracell | Clinical studies |
| Dr. Chronis Fatouros | Theracell | Molecular Biology and Genetics |
| Prof. Heiko Von Der Leyen | Hannover Medical School, Germany | Clinical studies |
| Dr. Dana Fuchs-Telem | Orgenesis Academy | Process Development |
| Dr. Sagi Nahum | Orgenesis Academy | Quality, Regulatory, Cell Processing |
| Chaya Mazouz, Msc | Orgenesis Academy | Quality, Regulatory |
| Dr. Fortis S | Univ. of WA | Cell Therapies clinical aspects |
| As. Porf. Themeli M | Univ. of Amsterdam, Netherlands | iPS, CART cells |
| Prof. Gerhard Bauer | UC Davis, California, USA | GMP operations, Clinical Production |
| Dr. Vasiliki Zacharioudaki | General University Hospital of Patras | Quality Management and Assurance, Cell Processing |
2nd Cycle (Academic year 2022-2023)
| Name | Institution | Area of Expertise |
|---|---|---|
| Prof. Spyridonidis Alexandros | Univ. of Patras | ATMPs, GMP, Regulations, clinical |
| Prof. Mouzaki Athanasia | Univ. of Patras | Immunology |
| Prof. Lygerou Zoi | Univ. of Patras | Cell cycle |
| Prof. Gerhard Bauer | UC Davis, California, USA | GMP operations, Clinical Production |
| Prof. Mougiakakos Dimitris | University of Magdeburg, Germany | Haematology, Immunotherapy |
| Prof. Papageorgiou Efstathia | Univ. of WA | Statistical process and medical data analysis |
| As. Prof. Kriebardis A. | Univ. of WA | Cell biology |
| As. Prof. Zoumboulakis P. | Univ. of WA | Biomarkers, Scientific Management |
| As. Prof. Nika Konstatnina | Univ. of Patras | Immunology, Cell signaling, T cell biology |
| Georgatzakou Chara, PhD | Univ. of WA | Cell biology |
| As. Prof. Psatha Nikoleta | Aristotle University of Thessaloniki | Ex vino & in vivo Gene Therapy |
| As. Prof. Themeli M. | Univ. of Amsterdam, Netherlands | iPS, CART cells |
| Dr. Georgios Katsouleas | Univ. of WA | Statistical process and data analysis |
| As. Prof. Hatzimichael Eleftheria | Univ. of Ioannina | |
| Vivian Tseveleki, PhD | Theracell | Clinical studies |
| Fortis S, PhD | Univ. of WA | Cell Therapies clinical aspects |
| Chronis Fatouros, PhD | Theracell | Molecular Biology and Genetics |
| Prof. Heiko Von Der Leyen | Hannover Medical School, Germany | Clinical studies |
| As. Prof. Eleni Gavriilaki | Aristotle University of Thessaloniki | Hematology |
| Sagi Nahum, PhD | Orgenesis Academy | Quality, Regulatory, Cell Processing |
| Chaya Mazouz, Msc | Orgenesis Academy | Quality, Regulatory |
| Prof. Martin Hildebrandt | TU Munich School of Medicine | GMP manufacturing |
| Dr. Katsila Theodora, PhD | National Hellenic Research Foundation | Biomarkers, ADME-Tox profiling, 3D-omics |
| Dr. Eyal Neria, PhD | Orgenesis Academy | Product Development |
| Dr. Stephen Minger, PhD | Orgenesis Academy | Regenerative Medicine, Stem Cells |
| Dr. Reem Miari, PhD | Orgenesis Academy | Biotechnology |
| Dr. Sandra Albrecht, PhD | Orgenesis Academy | Clinical Science |
| Dr. Bettina Rohde, PhD | Orgenesis Academy | Regulatory, clinical trials |
| Dr. Anke Lührmann, PhD | Orgenesis Academy | QM, Immunobiology |
| Dr. Sagi Nahum | Orgenesis Academy | Quality, Regulatory, Cell Processing |
| Vincent Vandamme, MSc | Orgenesis Academy | Quality/Operations |
| Miri Sani, MSc | Orgenesis Academy | Clinical studies |
| Chaya Mazouz, MSc | Orgenesis Academy | Quality, Regulatory |
| Tamar Shatil, MSc | Orgenesis Academy | |
| Dr. Dotan Uzi | Orgenesis Academy | |
| Dionisia Kefala, MSc phD Candidate | Univ. of Patras |
Invited Lecturers/ Tutors
| Name | Institution | Area of Expertise |
|---|---|---|
| Prof. Heiko von der Leyen | Orgenesis Academy/ Hannover Medical School, Germany | Clinical development of ATMPs |
| Prof. Martin Hildebrandt | TU Munich School of Medicine | GMP manufacturing |
| Prof. Tsirigotis P. | University of Athens | Clinical Cell therapy, Apheresis |
| Katsila Theodora, PhD | National Hellenic Research Foundation | Biomarkers, ADME-Tox profiling, 3D-omics |
| Papadopoulou A., PhD | Gene Therapy Unit Papanikolaou Hospital | Regulations, GMP, Production |
| Eyal Neria, PhD | Orgenesis Academy | Product Development |
| Stephen Minger, PhD | Orgenesis Academy | Regenerative Medicine, Stem Cells |
| Reem Miari, PhD | Orgenesis Academy | Biotechnology |
| Sandra Albrecht, PhD | Orgenesis Academy | Clinical Science |
| Bettina Rohde, PhD | Orgenesis Academy | Regulatory, clinical trials |
| Anke Lührmann, PhD | Orgenesis Academy | QM, Immunobiology |
| Vered Aviv, PhD | Orgenesis Academy | Adenoviruses |
| Vincent Vandamme, MSc | Orgenesis Academy | Quality/Operations |
| Vered Caplan, Msc | Orgenesis Academy | Biotechnology, Industry, Patents |
| Miri Sani, MSc | Orgenesis Academy | Clinical studies |
| Nufar Gross, Msc | Orgenesis Academy | GMP manufacturing |
Key information
3rd Cycle of Students
To be announced
(approximately September 2023)
To be announced
(approximately October 2023)
2 semesters, 60 ECTS credits
English
Worker friendly (evening/ WE classes)
Mostly Synchronous Online Courses (Σύγχρονη Εξ αποστάσεως Εκπαίδευση)
Labs on the Weekend
Asychronous Online Courses could be used
4.000 € (exemptions and scholarships available)
This course is a bi-institutional programme of postgraduate studies of the School of Medicine of Patras and the Dept. of Biomedical Sciences of the University of West Attica.
Sponsored by 
School of Medicine
University of Patras
University Campus, 26504 Rio Achaia
Secretary of MSc,
Mary Arioglou
Tel +302105387330, +302105381071
maryarioglou@upatras.gr , mscgt@upatras.gr
Administrative Secretary,
Maria Tsima
Secretary of Department of Medicine, University of Patras
Ms. Aikaterini Michalopoulou
Tel +30-2610969106
To see all the documents press here.
@Created by ADS-Solutions
